| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2003 : ICAAC 2003 : PK-PD Target Attainment with Monte Carlo Simulation as Decision Support of Phase 2 / 3 Dosing Strategies for the Clinical Development of Doripenem | published Mon, Nov 10, 2008 - 15:27 EST |
Primary Author: Sujata Bhavnani
Primary Author: Sujata M. Bhavnani, B.S., Pharm.D. Cognigen Corporation
Event: ICAAC 2003 Chicago, IL
Other Contributors: J.P. Hammel(1), B.B. Cirincione(1), D. Thye(2), M.A. Wikler(2), and P.G. Ambrose(1)
(1)Cognigen Corporation, Buffalo, NY; (2) Peninsula Pharmaceuticals, Inc., Alameda, CA
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2003 : ICAAC 2003 : PK-PD Target Attainment with Monte Carlo Simulation as Decision Support of Phase 2 / 3 Dosing Strategies for the Clinical Development of Doripenem | published Mon, Nov 10, 2008 - 15:27 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |